Summary
Elevance Health, Inc. (formerly WellPoint, Inc. at the time of this filing) filed an 8-K on April 30, 2014, to report its financial results for the first quarter ended March 31, 2014. The filing itself is primarily a notification of the release of their quarterly earnings, with the detailed financial data and commentary contained within the furnished press release (Exhibit 99.1). Investors should note that this report serves as a formal record of the earnings announcement. For specific financial performance metrics, revenue figures, earnings per share, and management's outlook, they would need to refer to the referenced press release. This 8-K signals the availability of that crucial information for public consumption and analysis.
Key Highlights
- 1WellPoint, Inc. (now Elevance Health) filed an 8-K on April 30, 2014, to disclose its Q1 2014 financial results.
- 2The report officially announces the release of the company's first-quarter financial performance.
- 3Key financial details and operational commentary are provided in a press release, filed as Exhibit 99.1.
- 4The filing indicates the company's adherence to SEC reporting requirements for timely financial disclosure.
- 5Investors are directed to the furnished press release for comprehensive Q1 2014 financial data and analysis.
- 6The event date for the reporting of these results was April 29, 2014.
Frequently Asked Questions
The primary purpose of this 8-K filing is to formally announce and provide access to WellPoint, Inc.'s (now Elevance Health) financial results for the first quarter ended March 31, 2014. It serves as an official notification to investors and the market that these results have been released.
The detailed financial results, including revenue, earnings, and management's commentary, are contained within the press release dated April 30, 2014, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for comprehensive information.
No, this specific 8-K filing itself does not contain the detailed financial figures. It only reports that a press release with these results has been issued and furnished as an exhibit. The actual financial numbers and performance analysis are in the referenced press release (Exhibit 99.1).
The 'Event date' (April 29, 2014) likely refers to the date the earnings were determined or officially communicated internally or to stakeholders, while the 'Filed' date (April 30, 2014) is the date the company submitted this 8-K report to the SEC, making the information publicly accessible.